← All trials
NCT06825494
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 8, 2025
- Primary completion
- Mar 31, 2026
- Completion date
- Sep 30, 2026
- First posted
- Feb 13, 2025
- Last posted
- Apr 18, 2025
- Enrollment
- 134
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.